Complementary roles in cancer prevention: Protease inhibitor makes the cancer preventive peptide Lunasin bioavailable

PLoS ONE

Volumn 5, Issue 1, 2010, Pages

  Hsieh, Chia Chien ^a   Hernández Ledesma, Blanca ^a   Jeong, Hyun Jin ^b   Park, Jae Ho ^b   De Lumen, Ben O ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b Andong National University   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; BOWMAN BIRK INHIBITOR; LUNASIN; PANCREATIN; SOYBEAN TRYPSIN INHIBITOR; UNCLASSIFIED DRUG; GM2S 1 PROTEIN, GLYCINE MAX; GM2S-1 PROTEIN, GLYCINE MAX; PROTEINASE INHIBITOR; SOYBEAN PROTEIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTINEOPLASTIC ACTIVITY; ARTICLE; BODY WEIGHT; BREAST CANCER; CANCER CELL CULTURE; CANCER INCIDENCE; CANCER PREVENTION; CELL DEATH; CELL PROLIFERATION; COMPARATIVE STUDY; CONTROL GROUP; CONTROLLED STUDY; DRUG ABSORPTION; DRUG BIOAVAILABILITY; DRUG DISTRIBUTION; DRUG EFFICACY; DRUG INHIBITION; FEMALE; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; IN VITRO STUDY; MALE; MOUSE; NONHUMAN; NUDE MOUSE; POLYACRYLAMIDE GEL ELECTROPHORESIS; RAT; WESTERN BLOTTING; XENOGRAFT; ANIMAL; BIOAVAILABILITY; EXPERIMENTAL NEOPLASM;

GLYCINE MAX; MUS; MUS MUSCULUS; RATTUS;

ANIMALS; BIOLOGICAL AVAILABILITY; MICE; NEOPLASMS, EXPERIMENTAL; PROTEASE INHIBITORS; RATS; SOYBEAN PROTEINS; TRANSPLANTATION, HETEROLOGOUS;

EID: 77749251910     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0008890     Document Type: Article

References (41)

1. Barnes S, Setchell KDR, Carlson J (1990) Mutagens and carcinogens in the diet. In: Pariza MW, Sato S, Felton JS, Aeschabacher HU, eds. Progress in clinical and biological research. New York: Wiley-Liss. pp 239-254.
2. Hakkak R, Korourian S, Shelnutt SR, Lensing S, Ronis MJJ, et al. (2000) Diets containing whey proteins or soy protein isolate protect against 7,12-Dimethylbenz(a)anthracene-induced mammary tumors in female rats. Cancer Epidemiol Biomarkers Prev 9: 113-117.
3. Mukhopadhyay S, Ballard BR, Mukherjee S, Kabir SM, Das SK (2006) Beneficial effects of soy protein in the initiation and progression against dimethylbenz [a] anthracene-induced breast tumors in female rats. Mol Cell Biochem 290: 169-176.
4. Troll W, Wiesner R, Shellabarger J, Holtzman S, Stone JP (1980) Soybean diet lowers breast tumor incidence in irradiated rats. Carcinogenesis 1: 469-472.
5. Galvez AF, de Lumen BO (1999) A soybean cDNA encoding a chromatin-binding peptide inhibits mitosis of mammalian cells. Nature Biotechnol 17: 495-500.
6. Jeong HJ, Lam Y, de Lumen BO (2002) Barley lunasin suppresses ras-induced colony formation and inhibits core histone acetylation in mammalian cells. J Agric Food Chem 50: 5903-5908.
7. Jeong HJ, Jeong JB, Kim DS, Park JH, Lee JB, et al. (2007) The cancer preventive peptide lunasin from wheat inhibits core histone acetylation. Cancer Lett 255: 42-48.
8. Jeong JB, Jeong HJ, Park JH, Lee SH, Lee JR, et al. (2007) Cancer-preventive peptide lunasin from Solanum nigrum L. inhibits acetylation of core histones H3 and H4 and phosphorylation of retinblastoma protein (Rb). J Agric Food Chem 55: 10707-10713.
9. Silva-Sánchez C, Barba de la Rosa AP, León-Galván MF, de Lumen BO, de León-Rodríguez AG, et al. (2008) Bioactive peptides in amaranth (Amaranthus hypochondriacus) seed. J Agric Food Chem 56: 1233-1240.
10. Galvez AF, Chen N, Macasieb J, de Lumen BO (2001) Chemopreventive property of a soybean peptide (Lunasin) that binds to deacetylated histones and inhibits acetylation. Cancer Res 61: 7473-748.
11. Lam Y, Galvez AF, de Lumen BO (2003) Lunasin suppresses E1A-mediated transformation of mammalian cells but does not inhibit growth of immortalized and established cancer cell lines. Nutr. Cancer 47: 88-94.
12. Kennedy AR, Szuhaj BF, Newberne PM, Billings PC (1993) Preparation and production of a cancer chemopreventive agent, Bowman-Birk inhibitor concentrate. Nutr Cancer 19: 281-302.
13. Clemente A, Gee JM, Johnson IT, MacKenzie DA, Domoney C (2005) Pea (Pisum sativum L.) protease inhibitors from the Bowman-Birk class influence the growth of human colorectal adenocarcinoma HT29 cells in vitro. J Agric Food Chem 53: 8979-8986.
14. Losso JN (2008) The biochemical and functional food properties of the Bowman-Birk Inhibitor. Crit Rev Food Sci Nutr 48: 94-118.
15. Prasain JK, Barnes S (2007) Metabolism and bioavailability of flavonoids in chemoprevention: current analytical strategies and future prospectus. Mol Pharm 4: 846-864.
16. Park JH, Jeong HJ, de Lumen BO (2007) In vitro digestibility of the cancer-preventive soy peptides lunasin and BBI. J Agric Food Chem 55: 10703-10706.
17. de Lumen BO (2005) Lunasin: A cancer-preventive soy peptide. Nutr Rev 63: 16-21.
18. Hernández-Ledesma B, Hsieh CC, de Lumen BO (2009) Concentration of Lunasin and Bowman-Birk protease inhibitor in US commercial soy foods. Food Chem 115: 574-580.
19. (+/-) (p53 knockout) mice. Int J Toxicol 25: 219-228.
20. Scholzen T, Gerdes J (2000) The Ki-67 protein: from the known and the unknown. J Cell Physiol 182: 311-322.
21. Adlercreutz CHT, Goldin BR, Gorbach SL, Hockerstedt KAV, Watanabe S, et al. (1995) Soybean phytoestrogen intake and cancer risk. J Nutr 125: 757S-770S.
22. Banerjee S, Li Y, Wang Z, Sarkar FH (2008) Multi-targeted therapy of cancer by genistein. Cancer Lett 269: 226-242.
23. Béliveau R, Gingras D (2007) Role of nutrition in preventing cancer. Canadian Family Phys 53: 1905-1911.
24. de Kok TM, van Breda SG, Manson MM (2008) Mechanisms of combined action of different chemopreventive dietary compounds: a review. Eur J Nutr 47: 51-59.
25. Kennedy AR (1998) Chemopreventive agents: protease inhibitors. Pharmacol Ther 78: 167-209.
26. Dia VP, Torres S, de Luman BO, Erdman JW, de Mejia EG (2009) Presence of lunasin in plasma of men after soy protein consumption. J Agric Food Chem 57: 1260-1266.
27. Lambert JD, Hou Z (2008) Bioavailability and cancer preventive activity of green tea polyphenols. In: Watson R, Preedy V, eds. CABI. Botanical Medicine in Clinical Practice. CABI. pp 328-334.
28. Kennedy AR, Kritchevsky D, Shen WC (2003) Effects of spermine-conjugated Bowman-Birk inhibitor (Spermine-BBI) on carcinogenesis and cholesterol biosynthesis in mice. Pharm Res 20: 1908-1910.
29. Vantyghem SA, Wilson SM, Postenka CO, Al-Katib W, Tuck AB, et al. (2005) Dietary genistein reduces metastasis in a postsurgical orthotopic breast cancer model. Cancer Res 65: 3396-3403.
30. Power KA, Saarinen NM, Chen JM, Thompson LU (2006) Mammalian ligans enterolactone and enterodiol, alone and in combination with the isoflavone genistein, do not promote the growth of MCF-7 xenografts in ovariectomized athymic nude mice. Int J Cancer 118: 1316-1320.
31. 20 labeling: a sensitive marker of epidermal proliferation state. J Invest Dermatol 123: 530-536.
32. Kennedy AR, Billings PC, Maki PA, Newberne P (1993) Effects of various preparations of dietary protease inhibitors on oral carcinogenesis in hamsters induced by DMBA. Nutr Cancer 19: 191-200.
33. Kennedy AR, Beazer-Barclay Y, Kinzler KW, Newberne PM (1996) Suppression of carcinogenesis in the intestines of min mice by the soybeanderived Bowman-Birk inhibitor. Cancer Res 56: 679-682.
34. Zhang L, Wan XS, Donahue JJ, Ware JH, Kennedy AR (1999) Effects of the Bowman-Birk Inhibitor on clonogenic survival and cisplatin- or radiationinduced cytotoxicity in human breast, cervical and head and neck cancer cells. Nutr Cancer 33: 165-173.
35. Chen YW, Huang SC, Lin-Shiau SY, Lin JK (2005) Bowman-Birk inhibitor abates proteasome function and suppresses the proliferation of MCF7 breast cancer cells through accumulation of MAP kinase phosphatase-1. Carcinogenesis 26: 1296-1306.
36. Du X, Beloussow K, Shen WC (2001) Bowman-Birk protease inhibitor and its palmitic acis conjugate prevent 7,12-dimethylbenz[a]anthracence-induced transformation in cultured mouse mammary glands. Cancer Lett 164: 135-141.
37. Wan XS, Ware JH, Zhang L, Newberne PM, Evans SM, et al. (1999) Treatment with soybean-derived Bowman Birk Inhibitor increases serum prostate-specific antigen concentration while suppressing growth of human prostate cancer xenografts in nude mice. The Prostate 41: 243-252.
38. Reznikoff CA, Bertram JS, Brankow DW, Geidelberger C (1973) Quantitative and qualitative studies of chemical transformation of cloned C3H mouse embryo cells sensitive to postconfluence inhibition of cell division. Cancer Res 33: 3239-3249.
39. (1995) Simulated Gastric Fluid and Simulated Intestinal Fluid TS. In: Board of Trustees, editors. The United States Pharmacopeia 23, the National Formulary 18. Rockville, Maryland: The United States Pharmacopeial Convention. 2053 p.
40. Jeong HJ, Jeong JB, Kim DS, de Lumen BO (2007) Inhibition of core histone acetylation by the cancer preventive peptide lunasin. J Agric Food Chem 55: 632-637.
41. Mai Z, Blackburn GL, Zhou JR (2007) Soy phytochemicals synergistically enhance the preventive effect of tamoxifen on the growth of estrogen-dependent human breast carcinoma in mice. Carcinogenesis 28: 1217-1223.